Literature DB >> 4018671

Maternal and cord serum levels of tissue polypeptide antigen (TPA) in normal pregnancies.

K Bremme, P Eneroth, B Nilsson, M Olsson.   

Abstract

The tumor antigen and cytoskeleton protein tissue polypeptide antigen (TPA) have been determined in maternal serum throughout pregnancy. TPA levels in serum from pregnant women (n = 70) were not different from those in nonpregnant women (n = 61) until pregnancy week 28, from which time levels increased until parturition. Duplex pregnancies (n = 7) had higher serum TPA concentrations than simplex pregnancies, which was significant in pregnancy weeks 28 (p less than 0.014) and 32 (p = 0.05). Maternal serum TPA concentrations did not change during abortion or parturition and the mixed umbilical blood concentration of TPA equaled that in the mother's serum just after parturition. The correlation between placenta weight and maternal serum TPA levels was significant (p = 0.025). The decline of TPA after labor indicated a t1/2 for serum TPA of 7.5 days.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018671     DOI: 10.1159/000299020

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  A comparison between the composition of maternal peripheral plasma and plasma collected from the retroplacental compartment at caesarean section. A study on protein and steroid hormones and binding proteins.

Authors:  M Norman; C G Eriksson; P Eneroth
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Peri- and postoperative changes in serum levels of four tumor markers and three acute phase reactants in benign and malignant gynecological diseases.

Authors:  E Avall-Lundqvist; K Sjövall; L O Hansson; P Eneroth
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

3.  Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery.

Authors:  K Itahashi; N Inaba; I Fukazawa; H Takamizawa
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.